title: [Experimental study of protective mechanism of Lipo-PGE(1) on hepatic ischemia-reperfusion injury].
abstract: OBJECTIVE
  To explore protective mechanism of Lipo-PGE(1) on hepatic ischemia-reperfusion injury.
  
  
  METHODS
  Twenty-one adult dogs were divided into three groups randomly: CON group, IV group and SMA group, each group includes seven dogs. Animals were occluded porta hepatis 45 min and reperfused 60 min to establish I/R injury models. Lipo-PGE(1) administration was conducted once before porta occlusion 5 min and after reperfusion 60 min in IV and SMA group, the dosage of Lipo-PGE(1) was microgxkg(-1) and rate was 0.05 microgxkg(-1)xmin(-1); and 0.9% sodium chloride administration was conducted once at same time, the rate of NS was 2 mlxkg(-1). CT perfusion imaging, free pressure of portal vein, oxygen content of portal vein and hepatic oxygen delivery, index of liver function (ALT, LDH and TB) were performed in succession and compared before and after I/R. Simultaneously, the morphology of liver samples were observed by light microscope and electron microscope.
  
  
  RESULTS
  (1) The liver perfusion was markedly decreased in the CON group, and moderately decreased in IV group and mildly in SMA group. (2) There was no significant difference of CpvO(2) in group comparison (P > 0.05) before and after I/R, but there was an increasing tendency in SMA group after I/R. There was significant difference of HDO(2) in group comparison before and after I/R (P < 0.05), but mildly in SMA group. (3) FPP increased obviously after I/R in control group, but there were no significant differences in the other groups. (4) The serious injury of liver in CON group after I/R was detected under light microscope and electron microscope, and moderately improved in IV group and markedly improved in SMA group.
  
  
  CONCLUSIONS
  The protective mechanisms of Lipo-PGE(1) on hepatic ischemia-reperfusion injury include: improving microcirculation, releasing FPP, increasing CpvO(2) and HDO(2), as well as alleviating parenchyma injury.
authors.affiliation: Department of Interventional Radiology, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China.
authors.forename: Jia-ping
authors.initials: JP
authors.lastname: Li
authors.forename: Yu
authors.initials: Y
authors.lastname: Wang
authors.forename: Yong-hui
authors.initials: YH
authors.lastname: Huang
authors.forename: He-ping
authors.initials: HP
authors.lastname: Li
authors.forename: Wei
authors.initials: W
authors.lastname: Chen
authors.forename: Jian-yong
authors.initials: JY
authors.lastname: Yang
mesh_terms: D000527:Alprostadil / Q000494:pharmacology*; D000818:Animals; D004195:Disease Models, Animal; D004285:Dogs; D005260:Female; D008099:Liver / Q000098:blood supply*; D008107:Liver Diseases; D008297:Male; D010092:Oximetry; D010100:Oxygen / Q000378:metabolism; D015427:Reperfusion Injury / Q000517:prevention & control*
chemical_list: D000527:Alprostadil; D010100:Oxygen